Barclays’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-6,484
| Closed | -$36K | – | 4657 |
|
|
2022
Q2 | $36K | Hold |
6,484
| – | – | ﹤0.01% | 3861 |
|
|
2022
Q1 | $40K | Hold |
6,484
| – | – | ﹤0.01% | 4085 |
|
|
2021
Q4 | $58K | Sell |
6,484
-5,574
| -46% | -$49.9K | ﹤0.01% | 3016 |
|
|
2021
Q3 | $117K | Sell |
12,058
-23,807
| -66% | -$231K | ﹤0.01% | 3168 |
|
|
2021
Q2 | $296K | Sell |
35,865
-7,757
| -18% | -$64K | ﹤0.01% | 2719 |
|
|
2021
Q1 | $416K | Sell |
43,622
-94,847
| -68% | -$905K | ﹤0.01% | 2750 |
|
|
2020
Q4 | $1.29M | Sell |
138,469
-3,586
| -3% | -$33.4K | ﹤0.01% | 1841 |
|
|
2020
Q3 | $1.93M | Sell |
142,055
-2,116
| -1% | -$28.8K | ﹤0.01% | 1518 |
|
|
2020
Q2 | $2.79M | Buy |
+144,171
| New | +$2.79M | ﹤0.01% | 1256 |
|
|
2020
Q1 | – | Sell |
-86,770
| Closed | -$78K | – | 3679 |
|
|
2019
Q4 | $78K | Buy |
86,770
+13,820
| +19% | +$12.4K | ﹤0.01% | 3498 |
|
|
2019
Q3 | $75K | Buy |
72,950
+54,450
| +294% | +$56K | ﹤0.01% | 3538 |
|
|
2019
Q2 | $15K | Buy |
+18,500
| New | +$15K | ﹤0.01% | 3990 |
|